Home » Cardiovascular » REDUCE-IT: CV risk reduction with Icosapent ethyl for hypertriglyceridemia

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

REDUCE-IT: CV risk reduction with Icosapent ethyl for hypertriglyceridemia

2018, Cardiovascular risk reduction with Icosapent ethyl for hypertriglyceridemia, NEJM

Subscribe via email